NCT02234427View on ClinicalTrials.gov

Pharmacogenomics of Antiplatelet Response

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Atherosclerosis
Interventions
DRUG

Aspirin

2-week aspirin therapy (81mg/day)

Trial Locations (1)

21287

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02234427 - Pharmacogenomics of Antiplatelet Response | Biotech Hunter | Biotech Hunter